why choose us

First received: November 18, 2022

Clinical Trial: Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Postmenopausal Osteoporosis

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Open-label, Single-arm Clinical Trial to Evaluate the Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women

Brief Summary: To evaluate the effect of 1 year of risedronate treatment on the prevention of bone loss after denosumab discontinuation in denosumab-treated post-menopausal osteoporosis for a year

Read more